Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Epidemiology (Cambridge, Mass.)|January 26, 2016
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid ArthritisRishi J Desai, Daniel H Solomon, Sebastian Schneeweiss, et al.
Seminars in Arthritis and Rheumatism|May 25, 2016
Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United StatesNa Lu, Sharan K Rai, Robert Terkeltaub, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studySeoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, et al.
Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritisYinzhu Jin, Sarah K Chen, Hemin Lee, et al.
Circulation|December 11, 2020
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA TherapyChintan V Dave, Seoyoung C Kim, Allison B Goldfine, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2021
SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 DiabetesMin Zhuo, Julie M Paik, Deborah J Wexler, et al.
Epidemiology (Cambridge, Mass.)|March 21, 2023
Comparative Safety of Gout Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Clone-censor-weight Target Trial Emulation ApproachKazuki Yoshida, Jun Liu, Rishi J Desai, et al.
Pharmacoepidemiology and Drug Safety|February 2, 2023
Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims dataHemin Lee, Jeffrey A Sparks, Su Been Lee, et al.
Drugs & Aging|February 7, 2020
Risk of Cataract Surgery and Age-Related Macular Degeneration After Initiation of Denosumab vs Zoledronic Acid for Osteoporosis: A Multi-Database Cohort StudyHemin Lee, Yinzhu Jin, Miin Roh, et al.
Pharmacoepidemiology and Drug Safety|February 29, 2024
Risk of fall or fracture with concomitant use of prescription opioids and other medications in osteoarthritis patientsNazleen F Khan, Katsiaryna Bykov, Jeffrey N Katz, et al.
Pageof 19